After at least two years of treatment, GLP-1 users had a 37 percent higher chance of developing alopecia than patients taking SGLT-2 drugs and 68 percent higher odds than those taking DPP-4 drugs, both of which are also used to treat type 2 diabetes
Am J Cardiovasc Pathol 3(2):131142 Walter MF, Jacob RF, Jeffers B, Ghadanfar MM, Preston GM, Buch J, Mason RP (2004) Serum levels of thiobarbituric acid reactive substances predict cardiovascular events in patients with stable coronary artery disease: a longitudinal analysis of the PREVENT study
Weight loss of 2-5 kg is typical over 6-12 months
"Every morning I wake up and think " oh good, I get an ALOHA Bar
Fat Metabolism: a proper dosage of Ipamorelin impacts growth hormone release and could potentially support fat loss and improve body composition
doi: 10.2337/db25-0282 202 HuangDShenPWangCGaoJYeCWuF